J&J to Sell Remaining Stake in Kenvue Spinoff
By Dean Seal
Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting off the Tylenol and Benadryl maker.
Kenvue said Monday that it will launch a secondary underwritten offering for 182.3 million shares that Johnson & Johnson is providing in a debt-for-equity exchange with Goldman Sachs and JP Morgan.
If sold at Friday's closing price of $20.54, the offering would fetch around $3.75 billion.
Kenvue said that Johnson & Johnson will no longer own any of its stock once the offering is completed.
Johnson & Johnson held an initial public offering for Kenvue a year ago and then sold most of its shares in the company in August.
The healthcare giant previously said it wanted to untangle the consumer-health unit's finances and operations from its prescription-drugs and medical device businesses. The effort followed similar moves by Pfizer and Merck, which sold their consumer-health businesses.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
May 13, 2024 10:06 ET (14:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations
-
Real Estate: Interest Rate Movements Drive Performance
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities